Fred Alger Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Fred Alger Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-89,828	Closed	-$2.25M	–	565
2022 Q1	$2.25M	Sell	89,828 -62,269	-41%	-$1.75M	0.01%	336
2021 Q4	$5.54M	Buy	+152,097	New	+$5.34M	0.01%	289
2021 Q1	–	Sell	-23,235	Closed	-$1.44M	–	521
2020 Q4	$1.44M	Sell	23,235 -524	-2%	-$30K	﹤0.01%	346
2020 Q3	$1.3M	Sell	23,759 -6,241	-21%	-$336K	﹤0.01%	324
2020 Q2	$1.73M	Hold	30,000	–	–	0.01%	315
2020 Q1	$1.21M	Buy	30,000 +10,000	+50%	+$425K	0.01%	303
2019 Q4	$791K	Buy	+20,000	New	+$351K	﹤0.01%	361

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Fred Alger Management's CCXI Position: Q2 2022 in Review

Fred Alger Management sold out of ChemoCentryx, Inc. (CCXI) in Q2 2022, closing a stake of 89,828 shares — an estimated $2.25M sold.

Fred Alger Management first reported a position in CCXI in Q4 2019 and held it in 7 quarters. The position peaked at $5.54M in Q4 2021. 182 funds tracked by Wall St. Rank hold CCXI as of Q2 2022.

Fred Alger Management reported no remaining ChemoCentryx, Inc. position as of Q2 2022 after selling out during the quarter.
Fred Alger Management sold 89,828 ChemoCentryx, Inc. shares in Q2 2022, an estimated $2.25M.
Fred Alger Management first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 7 quarters.
Fred Alger Management's ChemoCentryx, Inc. position peaked at $5.54M in Q4 2021.
182 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2022.

Based on Fred Alger Management's 13F filing for Q2 2022, filed 15 Aug 2022.